Rising Incidence of Avian Flu Driving the Growth of the Asian and Africa Avian Flu Market

Avian influenza, commonly known as avian flu, is an infectious viral disease primarily affecting birds, particularly domestic poultry such as chickens and ducks. It is caused by influenza viruses of the family Orthomyxoviridae, with various strains, some of which can be highly pathogenic and result in severe illness and death among infected birds. Human infections with avian flu can occur, often through direct contact with infected birds or contaminated environments, leading to respiratory illness and, in some cases, severe complications. The disease poses a significant threat to the poultry industry and public health, necessitating ongoing surveillance and control measures.

The drivers of the avian flu market in Africa and Asia include several key factors, such as the increasing incidence of avian influenza outbreaks, which raises awareness and demand for enhanced biosecurity measures and vaccination programs among poultry producers. Rising poultry consumption and subsequent demand for poultry products lead to heightened focus on disease prevention to ensure food safety and security. Additionally, government initiatives and international support aimed at strengthening veterinary services and surveillance systems contribute to market growth. The growing awareness of the economic impacts of avian flu outbreaks on the poultry industry also drives investments in research and development of vaccines and treatment solutions, further shaping the market dynamics in these regions

Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/africa-and-asia-avian-flu-market

Data Bridge Market Research analyzes that the Africa and Asia Avian Flu Market is expected to grow at a CAGR of 7.8% in the forecast period of 2024 to 2031 and is expected to reach USD 778.58 million by 2031 from USD 431.40 million in 2023.

Key Findings of the Study

Growth of Poultry Farming Industry

The poultry farming industry in Africa and Asia is rapidly expanding due to rising consumer demand for poultry products and improved production capabilities. As more farms emerge and existing operations scale up, the density of poultry populations increases, creating a higher risk of avian flu outbreaks. This growing risk necessitates robust biosecurity measures and vaccination programs to protect both poultry and human populations from potential infections.

Consequently, the expansion of poultry farming directly correlates with a heightened demand for avian flu vaccines, diagnostics, and biosecurity solutions. Farmers are more inclined to invest in preventive measures to safeguard their livestock and ensure the stability of their operations, while governments and veterinary authorities are likely to support these initiatives to avert outbreaks that could lead to significant economic and health consequences.

For instance,

• In May 2024, according to an article published by POULTRY WORLD, in Asia, consumer preferences are shifting toward poultry, which currently accounts for 25% of total animal protein consumption, while seafood constitutes 50% and other animal proteins make up the remaining 25%. This trend indicates a gradual increase in poultry demand.

The growth in poultry consumption supports the expansion of the poultry farming industry, driving the need for enhanced biosecurity measures and vaccination programs in the African and Asian avian flu market

Report Scope and Market Segmentation

Segment Analysis

The Africa and Asia avian flu market is categorized into seven notable segments which are based on the strain, type, vaccine, vaccine category, application, end user, and distribution channel.

• On the basis of strain, Africa and Asia avian flu market is segmented into H5 Strain, H7 Strain and H9 Strain

In 2024, the H5 Strain segment of the product segment is expected to dominate the Africa and Asia avian flu market

In 2024, the H5 Strain segment is expected to dominate the Africa and Asia avian flu market with a market share of 46.79% in Africa and 41.17% in Asia  due to its high pathogenicity, transmission efficiency, and significant impact on poultry health and production

• On the basis of type, Africa and Asia avian flu market is segmented into Low Pathogenic Avian Influenza (LPAI) and Highly Pathogenic Avian Influenza (HPAI)

In 2024, the Low Pathogenic Avian Influenza (LPAI) segment of the product segment is expected to dominate the Africa and Asia avian flu market

 In 2024, the Low Pathogenic Avian Influenza (LPAI) segment is expected to dominate the African and Asia avian flu market with a market share of 61.31% in Africa and 57.19% in Asia  due to its widespread occurrence in wild birds and poultry, leading to significant economic impact without the lethality of high pathogenic strains.

• Based on vaccine, African and Asia avian flu market is segmented into Gallimune/ Gallivac/ Volvac, Nobilis influenza h5n2, Mefluvac, Viraflu and Others. In 2024, the Nobilis influenza h5n2 is expected to dominate the  African and Asia avian flu market with a market share of 75.99% in Africa due to their proven efficacy, safety profile, and ability to provide reliable protection against various strains of the virus in poultry
• Based on vaccine category, African and Asia avian flu market is segmented into inactivated vaccines, live recombinant vaccines, combination vaccines, and DNA vaccine. In 2024, inactivated vaccines segment is expected to dominate the Africa and Asia avian flu market with a market share of 69.02% in Africa and 65.75% in Asia  due to due to their proven efficacy, safety profile, and ability to provide reliable protection against various strains of the virus in poultry
• Based on application, Africa and Asia avian flu market is segmented into veterinary and human. In 2024, veterinary segment is expected to dominate the Africa and Asia avian flu market with a market share of 91.96% in Africa and 91.00% in Asia 
• Based on end user, Africa and Asia avian flu market is segmented into poultry farms, veterinary clinics, governmental organizations, research institutes, others. In 2024, Poultry Farms segment is expected to dominate the Africa and Asia avian flu market with a market share of 60.13% in Africa and 53.33% in Asia  due to the region's high reliance on poultry as a primary source of protein and income, necessitating robust disease management strategies
• Based on distribution channel, Africa and Asia avian flu market is segmented into direct tenders, third party distributor, and retail sales. In 2024,  direct tender segment is expected to dominate the Africa and Asia avian flu market with a market share of 50.83% in Africa and 44.92% in Asia  due to governmental and institutional procurement efforts aimed at quickly addressing outbreaks and ensuring a steady supply of vaccines and preventive measures

Major Players

Data Bridge Market Research recognizes the following companies as the major avian flu market players in the market that include  Boehringer Ingelheim International GmbH, Kemin Industries, Inc., Ceva, Merck & Co., Inc., China Animal Husbandry Group, Sinergium Biotech, and Qilu animal health products co., ltd.

Market Development

• In September2024 , Merck & Co., Inc. Animal Health partnered with the American Association of Bovine Practitioners Foundation to award USD 90,000 in scholarships to nine veterinary students. Each recipient received USD 10,000 at the 2024 AABP Annual Conference in Columbus, Ohio, recognizing their academic achievements and commitment to bovine veterinary medicine
• In August, Merck & Co.2024, Inc. Animal Health announced the USDA's approval of Cambridge Technologies’ experimental autogenous vaccine for avian metapneumovirus type B, the first such vaccine in the U.S. for poultry. This partnership enables Merck to act as the exclusive sales agent for Cambridge's innovative vaccines, which enhance immunity while minimizing adverse effects in birds
• In January2024, Ceva Santé Animal announced its acquisition of Scout Bio, a leader in pet biotechnology. This strategic move enhances Ceva's innovation capabilities, providing access to a pipeline of monoclonal antibodies and gene therapies for chronic pet diseases. The acquisition aims to accelerate biotherapeutic advancements while continuing Ceva's commitment to all species

Regional Analysis

Geographically, the city covered in the Asian and Africa avian flu  market report are the Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cabo Verde, Cameroon, Central African Republic, Chad, Comoros, Congo (rep), Côte D'ivoire, Djibouti, DRC, Egypt, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya,  Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Rwanda, São Tomé and Principe, Senegal, Seychelle, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Western Sahara, Zambia,  Zimbabwe, Rest of Africa, Afghanistan, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, China, India, Indonesia,  Japan, Kazakhstan, Kyrgyzstan,  Laos, Malaysia, Maldives, Mongolia, Myanmar, Nepal,  North Korea, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Tajikistan, Thailand, Timor-leste, Turkmenistan, Uzbekistan, Vietnam, and Rest of Asia.

Asia is expected to lead the Africa and Asia avian flu market as there is increasing healthcare expenditure, rising incidence of avian flu outbreaks and government initiatives and vaccination programs. In Asia China is expected to register lucrative growth in the forecast period of 2023 to 2031 owing to the rising level of healthcare expenditure and increasing per-capita income

For more detailed information about the Asian and Africa avian flu market report, click here – https://www.databridgemarketresearch.com/fr/reports/africa-and-asia-avian-flu-market